Correction to: “Response to Letter to the Editor From Luis Del Carpio-Orantes: [Impact of Surreptitious Glucocorticoids in Over-the-counter Arthritis Supplements]”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdrenal Hormones and Disorders · Rheumatoid Arthritis Research and Therapies · Systemic Lupus Erythematosus Research
In the above-named article by Wei KS, Hurtado CR, and Angell TE (J. Endocr Soc. 2025; 9(5); doi: 10.1210/jendso/bvaf045), there was an error in reference 1.
In the Letter Response as originally published, reference 1 appeared as “Del Carpio-Orantes L. Letter to editor: impact of surreptitious glucocorticoids in over-the-counter arthritis supplements. J Endocr Soc. 2024;9(2):bvae227. The corrected reference 1 is “Del Carpio-Orantes L. Letter to editor: impact of surreptitious glucocorticoids in over-the-counter arthritis supplements. J Endocr Soc. 2025; 9(6): bvaf044, https://doi.org/10.1210/jendso/bvaf044
The Letter Response has been corrected online.